Divyansh Agarwal
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (16)
Year:
2026
Year:
2026
Year:
2026
Background The early 20th century saw pioneering work by Frank and Lillian Gilbreth, regarded as the founders of surgical ergonomics, which brought scientific management in surgery and operating rooms. Through time and motion studies, their research helped improve the operative workflow and surgical efficiency. Methods To document the historical work of Gilbreths in surgical ergonomics, we conducted primary archival research at the Purdue University Archives and Special Collections (West Lafayette, IN), and integrated a collection of secondary sources across various formats and modalities. Results and Conclusion We describes the early works of Gilbreths in surgical ergonomics and highlight how their motion research in the operating room evolved to incorporate ergonomics and decrease operative fatigue. The Gilbreths were proponents of promoting the adoption of management practices for operating rooms and standardization in hospital design, equipment, and patient records to improve efficiency in health care delivery. Through analysis of their published and unpublished work, we describe how their ideas are still in widespread use today to eliminate unnecessary motions and foster ergonomics in the operating room and in the field of surgery in general.
Year:
2025
Year:
2025
Introduction For primary bilateral inguinal hernias, international guidelines favor a laparoscopic posterior mesh repair due to relatively lower risk of acute and chronic pain, faster recovery, and favorable biomechanical properties compared to open anterior approaches (Lichtenstein, plug and patch, etc.). However, studies comparing open mesh-based bilateral inguinal hernia repairs to bilateral laparoscopic and robotic mesh-based approaches are limited. The Abdominal Core Health Quality Collaborative (ACHQC) registry includes longitudinal data on bilateral inguinal hernia repairs performed via open as well as laparo-endoscopic approaches. We hypothesize that outcomes for bilateral inguinal hernia repair are similar between open and laparo-endoscopic approaches in the ACHQC registry. Methods Data from 2012 to 2024 was obtained from the ACHQC registry for individuals who underwent open and laparo-endoscopic bilateral inguinal hernia repair. After adjusting for confounding covariates, 3:1 propensity score-based matching was performed to compare patient-reported quality of life using EuraHS scores between the open, robotic, and laparoscopic bilateral inguinal hernia repair cohorts. Postoperative complications and hernia recurrences were also compared between these cohorts. Results In the matched analysis between laparoscopic, robotic, and open repair groups, 575, 524, and 208 individuals, respectively, were included. In the combined analysis comparing laparo-endoscopic to open repairs, data was included for 627 and 211 individuals, respectively, after propensity score matching with 3-year follow up. The open cohort comprised of approximately 40% open preperitoneal and 60% Lichtenstein repairs. The mean age of individuals in this study was 63 years (± standard deviation of 8 years), with nearly 92% of the patients being male (772/838). EuraHS scores up to the 3-year follow-up timepoint did not show statistical or clinical differences between the study cohorts ( p = 0.19). There were also no significant differences between the rates of hernia recurrence at 3-year follow up, 30-day surgical site occurrences, postoperative bleeding, peripheral nerve injury, venous thromboembolic events, and urinary tract infections between the three cohorts. Conclusion For individuals undergoing primary bilateral inguinal hernia repair, all three approaches– laparoscopic, robotic, and open– are comparable in surgical and patient-reported outcomes in the ACHQC registry. Given the high percentage of open preperitoneal repairs in this study, further investigation is warranted to understand if the “open” cohort outcomes are skewed by the combination of both anterior and posterior open repairs in the same group.
Year:
2025
We present the results of a randomized, open-label pilot study investigating the combination of oral vancomycin and stereotactic body radiotherapy (SBRT) in early-stage non-small cell lung cancer (NSCLC). Our findings highlight vancomycin’s safety, evidenced by the absence of Grade 3 or 4 adverse events, and its potential to enhance the antitumor efficacy of SBRT. The observed enhancement is linked to vancomycin’s modulation of the gut microbiota, which triggers significant metabolic changes and immune activation, thereby contributing to improved progression-free survival (PFS) and overall survival (OS). Patients received vancomycin (125 mg, four times daily for five weeks, starting one week prior to SBRT), which induced restructuring of the gut microbiome and significant changes in the gut metabolome. Key changes included reductions in short-chain fatty acids (SCFAs) and shifts in other immunomodulatory metabolites. These metabolic shifts were associated with the activation of dendritic cells and T cells, creating a pro-inflammatory environment conducive to strengthening SBRT’s antitumor efficacy. The combination of vancomycin and SBRT presents a novel, low-toxicity therapeutic approach for early-stage NSCLC, showing promising initial outcomes. While the results are encouraging, further research with larger cohorts is necessary to verify these findings and elucidate the underlying mechanisms that contribute to the observed clinical benefits. WHAT IS ALREADY KNOWN ON THIS TOPIC Radiation therapy is a primary treatment for early-stage non-small cell lung cancer and offers excellent local control in early-stage NSCLC, the challenges of regional and distant failures which occur in up to 50% of patients, lead to increased morbidity and mortality. The gut microbiome is increasingly recognized in cancer immunotherapy. RT can induce Immunogenic Cell Death, activating the immune system and promoting abscopal effect to impact untreated lesions. Our previous preclinical studies have shown that antibiotics like vancomycin can modulate these immune effects and enhance RT’s antitumor activity. WHAT THIS STUDY ADDS This clinical study corroborates our previous preclinical findings by demonstrating the safety of vancomycin and its potential to enhance the antitumor effects of RT, despite the small cohort size. These findings suggest that vancomycin could be strategically used to improve RT outcomes. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY Our findings prompt further investigation into this combined treatment in a larger patient cohort to confirm enhanced progression-free survival and overall survival. Exploring the impact on distal recurrences and applying this strategy to more advanced patient stages could significantly influence future research directions and clinical practices. This approach may also guide policy towards integrating microbiome modulation strategies in standard cancer treatment protocols.
Year:
2025
Single-cell RNA sequencing data enables analysis of transcript levels of single cells across different cell types and conditions. Recent work has highlighted the value of measuring gene-specific transcriptional variability, or noise, within a genetically identical population of cells in addition to mean expression given that these differences contribute to biological processes including development and disease. However, measuring transcriptional noise remains a challenge. Here, we systematically compared statistical methods by simulating single-cell data by varying both dispersion and count size to assess the relative responsiveness to noise of several commonly used statistical metrics: the Gini index, variance-to-mean ratio, variance, and Shannon entropy. We found that the variance-to-mean ratio scales approximately linearly with increasing dispersion and is scale-invariant. In contrast, the Gini index displayed paradoxical behavior, and Shannon entropy was not scale-invariant. Thus, we next applied the variance-to-mean ratio to measure transcriptional variability in a publicly available single-cell dataset of embryonic hearts from a mouse model of maternal hyperglycemia. Our data show that many genes display transcriptional variability within the same cell type, and that this variation does not correlate with gene characteristics such as transcript level, promoter GC content, or evolutionary gene age. Notably, many of the genes and pathways with highest transcriptional variability were not identified as differentially expressed, and have in fact been implicated in maternal hyperglycemia in other studies, suggesting that transcriptional variability can provide additional biologically relevant information beyond what is observed from studying mean expression alone.
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (10)
Amit Maity
Professor and Chair of Dept. of Radiation Oncology
University of Utah
david o'connor
Professor
University of Wisconsin-Madison
Jeffrey D. Bradley
Professor and Vice Chair
Hospital of the University of Pennsylvania
Roddy S. O'Connor
Assistant Professor
University of Pennsylvania
Francesca Costabile
University of Pennsylvania
Shane Lloyd
-
Kyle Bittinger
Children's Hospital of Philadelphia
Kaela Blake
Assistant Professor
University of Tennessee Medical Center
Costas Koumenis
Richard H. Chamberlain Professor with Tenure
University of Pennsylvania Perelman School of Medicine
Andrea Facciabene
University of Pennsylvania Perelman School of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.